Study on the Safety of the Drug BAY2395840 at Different Doses, the Way the Body Absorbs, Distributes and Excretes the Drug Including the Effect of Its Formulation (Tablet or Liquid) and the Effect of Food on the Absorption, Distribution or Excretion of the Drug in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 18, 2019

Primary Completion Date

December 17, 2020

Study Completion Date

March 11, 2021

Conditions

Endometriosis

Interventions

DRUG

BAY2395840 tablet

tablets, oral administration

DRUG

BAY2395840 oral solution

solution, oral administration

DRUG

Placebo oral solution

Placebo matching BAY2395840, oral administration

DRUG

Placebo tablet

Placebo matching BAY2395840, oral administration

Trial Locations (1)

CRS Clinical Research Services Berlin GmbH, Berlin